Clinical Trial Update: A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of SAR445399 in adults with moderate to severe hidradenitis suppurativa,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• SAR445399

Snippet

Sponsor: Sanofi | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: RECRUITING